Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1967 Sep;26(5):373–388. doi: 10.1136/ard.26.5.373

Assessment of drugs in out-patients with rheumatoid arthritis. Evaluation of methods and a comparison of mefenamic and flufenamic acids with phenylbutazone and aspirin.

R M Mason, D E Barnardo, W R Fox, M Weatherall
PMCID: PMC1031343  PMID: 6039589

Full text

PDF
373

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnardo D. E., Currey H. L., Mason R. M., Fox W. R., Weatherall M. Mefenamic acid and flufenamic acid compared with aspirin and phenylbutazone in rheumatoid arthritis. Br Med J. 1966 Aug 6;2(5509):342–343. doi: 10.1136/bmj.2.5509.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. COCHRANE A. L., CHAPMAN P. J., OLDHAM P. D. Observers' errors in taking medical histories. Lancet. 1951 May 5;1(6662):1007–1009. doi: 10.1016/s0140-6736(51)92518-4. [DOI] [PubMed] [Google Scholar]
  3. COODLEY E. L. Evaluation of drug therapy in rheumatoid arthritis-study of flufenamic acid. West Med Med J West. 1963 Jul;4:228–232. [PubMed] [Google Scholar]
  4. Currey H. L. Intra-articular thiotepa in rheumatoid arthritis. Ann Rheum Dis. 1965 Jul;24(4):382–388. doi: 10.1136/ard.24.4.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis. 1959 Mar;18(1):49–53. [PMC free article] [PubMed] [Google Scholar]
  6. DIXON W. M., STRADLING P., WOOTTON I. D. Outpatient P.A.S. therapy. Lancet. 1957 Nov 2;273(7001):871–872. doi: 10.1016/s0140-6736(57)90006-5. [DOI] [PubMed] [Google Scholar]
  7. Donnelly P., Lloyd K., Campbell H. Indomethacin in rheumatoid arthritis: an evaluation of its anti-inflammatory and side effects. Br Med J. 1967 Jan 14;1(5532):69–75. doi: 10.1136/bmj.1.5532.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fearnley M. E., Masheter H. C. New drugs. VII. A controlled trial of flufenamic acid therapy in rheumatoid arthritis. Ann Phys Med. 1966 May;8(6):204–207. doi: 10.1093/rheumatology/8.6.204. [DOI] [PubMed] [Google Scholar]
  9. HART F. D., CLARK C. J. M. Measurement of digital swelling in rheumatoid arthritis. Lancet. 1951 Apr 7;1(6658):775–775. doi: 10.1016/s0140-6736(51)92192-7. [DOI] [PubMed] [Google Scholar]
  10. MASON R. M. Clinical trials. Proc R Soc Med. 1962 Jun;55:512–516. [PMC free article] [PubMed] [Google Scholar]
  11. REYNOLDS E., JOYCE C. R., SWIFT J. L., TOOLEY P. H., WEATHERALL M. PSYCHOLOGICAL AND CLINICAL INVESTIGATION OF THE TREATMENT OF ANXIOUS OUT-PATIENT WITH THREE BARBITURATES AND PLACEBO. Br J Psychiatry. 1965 Jan;111:84–95. doi: 10.1192/bjp.111.470.84. [DOI] [PubMed] [Google Scholar]
  12. Rajan K. T., Hill A. G., Barr A., Whitwell E. Flufenamic acid in rheumatoid arthritis. Ann Rheum Dis. 1967 Jan;26(1):43–46. doi: 10.1136/ard.26.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Simpson M. R., Simpson N. R., Masheter H. C. New drugs. 8. Flufenamic acid in rheumatoid arthritis. Comparison with aspirin and the results of extended treatment. Ann Phys Med. 1966 May;8(6):208–213. [PubMed] [Google Scholar]
  14. WINDER C. V., WAX J., SCOTTI L., SCHERRER R. A., JONES E. M., SHORT F. W. Anti-inflammatory, antipyretic and antinociceptive properties of N-(2,3-xylyl)anthranilic acid (mefenamic acid). J Pharmacol Exp Ther. 1962 Dec;138:405–413. [PubMed] [Google Scholar]
  15. Willcox D. R., Gillan R., Hare E. H. Do psyhiatric out-patients take their drugs? Br Med J. 1965 Oct 2;2(5465):790–792. doi: 10.1136/bmj.2.5465.790. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES